Cardia Secures European Patent Protection for Its Bioplastics Technology
• European Patent Office grants cornerstone patent for Cardia Compostable resin and process technology.
• Cardia Bioplastics expands patent portfolio to twenty-eight registered patents protecting its bioplastics technologies with thirty-nine more patents pending registration.
• Cardia’s proprietary innovation in compostable, Biohybrid™ and PPC-starch technologies validated through international patents.
• Cardia capitalises on growth of bioplastics with leading brand owners and government bodies where strong intellectual property position is a key requirements for commercial success.
Sealed Air PakNatural® Biodegradable Cushion Bags made from Cardia’s proprietary Compostable films, now patent protected in Europe.
Cardia Bioplastics, a subsidiary of SECOS Group Limited (ASX: SES), is pleased to announce that it secured European patent protection for its bioplastics technology. The European Patent 2052030 was granted for Cardia’s unique and innovative compostable resin formulations and production processes.
Nine new Cardia Compostable, Biohybrid™ and PPC-starch technology patents have been granted in 2015. These new patents expand Cardia Bioplastics growing intellectual property portfolio of 11 patent families, with twenty-eight patents so far granted in Europe, USA, Australia, China, Japan, New Zealand and South Africa, and thirty-nine more patents pending registration. The patents protect the composition formulations, manufacturing processes and application technology invented by Cardia’s Research Development team.
On receiving the news, Dr. Frank Glatz, Chief Executive Officer of Cardia Bioplastics said, “This marks an important milestone for Cardia Bioplastics. These granted patents protect the intellectual property of the Company and further support the technical differentiation of our globally certified Cardia Compostable and independently validated lower carbon foot print Cardia Biohybrid™ product offering.”
Cardia’s proprietary compostable resins technology delivers homogeneous and well compatabilised materials that are differentiated in their product performance. Cardia Compostable films are strong and tough with good sealability and long shelf life. They display superior puncture, tear resistance and impact toughness. Cardia Compostable products are breathable and therefore great for controlling odour and dissipating moisture. The Cardia technical team has proven with third parties the Cardia Compostable products composting performance in industrial operations and at home.
Cardia Compostable resins are certified biodegradable and compostable to international standards including Europe EN13432, USA ASTM D6400, Australia AS4736 and Japan Green Pla and are used in a wide variety of applications from films, bags and moulded products to waste management items.
The biodegradable and compostable plastics market is projected to continue its rapid growth due to increased Government regulation of environmental issues and waste management. Organic waste diversion is being implemented around the world using compostable waste management bags. Leading brand owners and consumers increasingly demand sustainable packaging solutions. ‘Markets and Markets Research Group’ predicts the global biodegradable and compostable plastics market to be worth more than US$ 3.4 billion by 2020. (1)
Dr. Frank Glatz continues, “Customers like our resins and finished products. With our strong patent portfolio, biodegradable and compostable certifications and high product performance, Cardia is gaining traction in the international compostable plastics market.”
(1) Markets and Markets Research Group, Biodegradable Plastics Market by Type, by Application - Global Trends Forecasts to 2020
About Cardia Bioplastics
Cardia Bioplastics, a subsidiary of SECOS Group Limited (ASX: SES), develops, manufactures and markets its patented renewable resource-based materials and finished products derived from Cardia’s proprietary technology for the global packaging and plastic products industries. The company holds a strong patent portfolio and its growth is fuelled by the global trend towards sustainable packaging. Established in Australia in 2002, the company Headquarters and Global Application Development Centre is in Melbourne, Australia. Cardia Bioplastics’ Product Development Centre and manufacturing plant for resins, film and bag products are in Nanjing, China. Cardia has further offices in Australia, China, USA and Malaysia, and a network of leading distributors across the Americas, Asia and Europe. For further information visit cardiabioproducts.com  and cardiabioplastics.com.
Further information
Dr. Frank Glatz
Chief Executive Officer
Cardia Bioplastics
+61 400 930 530
f.glatz@cardiabioplastics.com
Nadya Krienke-Becker
Global Head of Marketing
Cardia Bioplastics
+61 414 672 863
n.krienke-becker@cardiabioplastics.com
www.cardiabioplastics.com
info@cardiabioplastics.com
